Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Vanda Pharmaceuticals Inc. | d824216d10k.htm |
| EX-31.2 - EX-31.2 - Vanda Pharmaceuticals Inc. | d824216dex312.htm |
| EX-31.1 - EX-31.1 - Vanda Pharmaceuticals Inc. | d824216dex311.htm |
| EX-10.58 - EX-10.58 - Vanda Pharmaceuticals Inc. | d824216dex1058.htm |
| EX-32.1 - EX-32.1 - Vanda Pharmaceuticals Inc. | d824216dex321.htm |
| EX-10.62 - EX-10.62 - Vanda Pharmaceuticals Inc. | d824216dex1062.htm |
| EX-10.59 - EX-10.59 - Vanda Pharmaceuticals Inc. | d824216dex1059.htm |
| EX-10.60 - EX-10.60 - Vanda Pharmaceuticals Inc. | d824216dex1060.htm |
| EX-10.55 - EX-10.55 - Vanda Pharmaceuticals Inc. | d824216dex1055.htm |
| EX-10.61 - EX-10.61 - Vanda Pharmaceuticals Inc. | d824216dex1061.htm |
| EX-10.56 - EX-10.56 - Vanda Pharmaceuticals Inc. | d824216dex1056.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Vanda Pharmaceuticals Inc. | Financial_Report.xls |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-133368, No. 333-138070, No. 333-141571, No. 333-148924, No. 333-156995, No. 333-164567, No. 333-171962, No. 333-179265, No. 333-186509, No. 333-193614 and No. 333-201754) and on Form S-3 (No. 333-191434) of Vanda Pharmaceuticals Inc. of our report dated March 13, 2015 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
McLean, Virginia
March 13, 2015